Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile AcidsLorenzo Guidetti, Riccardo Castelli, Laura Scalvini, et al.Molecules (Basel, Switzerland)|September 23, 2015
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor AntagonistsDonatella Callegari, Daniele Pala, Laura Scalvini, et al.Journal of Chemical Information and Modeling|January 17, 2025
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy SimulationsLaura Scalvini, Daniele Pala, Alberto Cuzzolin, et al.Journal of Medicinal Chemistry|February 27, 2015
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer TreatmentMatteo Santucci, Tatiana Vignudelli, Stefania Ferrari, et al.Journal of Pharmaceutical and Biomedical Analysis|January 1, 2020
Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in miceFrancesca Ferlenghi, Riccardo Castelli, Laura Scalvini, et al.Scientific Reports|August 9, 2016
Free-energy studies reveal a possible mechanism for oxidation-dependent inhibition of MGLLaura Scalvini, Federica Vacondio, Michele Bassi, et al.Molecules (Basel, Switzerland)|September 9, 2020
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational EquilibriaGian Marco Elisi, Annalida Bedini, Laura Scalvini, et al.Cancers|September 19, 2018
Repurposing of Drugs Targeting YAP-TEAD FunctionsGian Marco Elisi, Matteo Santucci, Domenico D'Arca, et al.Biochemical Pharmacology|February 15, 2023
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approachFrancesca Romana Ferrari, Carmine Giorgio, Alfonso Zappia, et al.Plos One|June 9, 2015
Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in RatsFederica Vacondio, Michele Bassi, Claudia Silva, et al.Pageof 5